Mesenchymal stem cells pretreated with HGF and FGF4 can reduce liver fibrosis in mice

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Shams, Sulaiman ^a,b   Mohsin, Sadia ^a   Nasir, Ghazanfar Ali ^a   Khan, Mohsin ^a   Khan, Shaheen N ^a  

^a National Centre of Excellence in Molecular Biology   (Pakistan)

^b ABDUL WALI KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BILIRUBIN; CARBON TETRACHLORIDE; CASPASE 3; COLLAGEN; CYTOKERATIN 8; FIBROBLAST GROWTH FACTOR 4; GLYCOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL XL; SCATTER FACTOR;

ALBUMIN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAX GENE; BCL 2 GENE; BCL XL GENE; BETA ACTIN GENE; CASPASE 3 GENE; CELL HOMING; CELL LABELING; CELL PROTECTION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYT 18 GENE; CYT 8 GENE; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CELL; LIVER FIBROSIS; LIVER FUNCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NF KAPPA BETA GENE; NICK END LABELING; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; TNF ALPHA GENE;

MUS;

EID: 84922344485     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/747245     Document Type: Article

References (29)

1. S. L. Friedman, "Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications, " Nature Clinical Practice: Gastroenterology and Hepatology, vol. 1, no. 2, pp. 98-105, 2004.
2. D. C. Zhao, J. X. Lei, R. Chen et al., "Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats, " World Journal of Gastroenterology, vol. 11, no. 22, pp. 3431-3440, 2005.
3. A. B. Carvalho, L. F. Quintanilha, J. V. Dias et al., "Bonemarrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury, " Stem Cells, vol. 26, no. 5, pp. 1307-1314, 2008.
4. L. Liang, T. Ma, W. Chen et al., "Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury, " Hepatology Research, vol. 39, no. 8, pp. 822-832, 2009.
5. V. Rabani, M. Shahsavani, M. Gharavi, A. Piryaei, Z. Azhdari, and H. Baharvand, "Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression, " Cell Biology International, vol. 34, no. 6, pp. 601-605, 2010.
6. M. R. Alison, R. Poulsom, R. Jeffery et al., "Hepatocytes from non-hepatic adult stem cells, " Nature, vol. 406, no. 6793, p. 257, 2000.
7. N. D. Theise, M. Nimmakayalu, R. Gardner et al., "Liver from bone marrow in humans, " Hepatology, vol. 32, no. 1, pp. 11-16, 2000.
8. S. Wakitani, T. Saito, and A. I. Caplan, "Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine, " Muscle and Nerve, vol. 18, no. 12, pp. 1417-1426, 1995.
9. S. P. Bruder, N. Jaiswal, and S. E. Haynesworth, "Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation, " Journal of Cellular Biochemistry, vol. 64, no. 2, pp. 278-294, 1997.
10. D. J. Prockop, "Marrow stromal cells as stem cells for nonhematopoietic tissues, " Science, vol. 276, no. 5309, pp. 71-74, 1997.
11. P. P. Wang, J. H. Wang, Z. P. Yan et al., "Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction, " Biochemical and Biophysical Research Communications, vol. 320, no. 3, pp. 712-716, 2004.
12. S. Oyagi, M. Hirose, M. Kojima et al., "Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats, " Journal of Hepatology, vol. 44, no. 4, pp. 742-748, 2006.
13. B. Fang, M. Shi, L. Liao, S. Yang, Y. Liu, and R. C. Zhao, "Systemic infusion of FLK1+ mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrcosis in mice, " Transplantation, vol. 78, no. 1, pp. 83-88, 2004.
14. T. Ishikawa, S. Terai, Y. Urata et al., "Administration of fibroblast growth factor 2 in combination with bone marrow transplantation synergistically improves carbon-tetrachloride-induced liver fibrosis in mice, " Cell and Tissue Research, vol. 327, no. 3, pp. 463-470, 2007.
15. M. Khan, S. Mohsin, S. N. Khan, and S. Riazuddin, "Repair of senescentmyocardiumbymesenchymal stem cells is dependent on the age of donor mice, " Journal of Cellular and Molecular Medicine, vol. 15, no. 7, pp. 1515-1527, 2011.
16. S. Mohsin, S. Shams, G. Ali Nasir et al., "Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue, " Differentiation, vol. 81, no. 1, pp. 42-48, 2011.
17. P. O. Seglen, "Preparation of isolated rat liver cells., " Methods in cell biology, vol. 13, pp. 29-83, 1976.
18. I. Sakaida, S. Terai, N. Yamamoto et al., "Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice, " Hepatology, vol. 40, no. 6, pp. 1304-1311, 2004.
19. K. Moriya, M. Yoshikawa, K. Saito et al., "Embryonic stem cells develop into hepatocytes after intrasplenic transplantation in CCl4-treated mice, " World Journal of Gastroenterology, vol. 13, no. 6, pp. 866-873, 2007.
20. G. A. Nasir, S. Mohsin, M. Khan et al., "Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice, " Journal of Translational Medicine, vol. 11, no. 1, article 78, 2013.
21. R. Higashiyama, Y. Inagaki, Y. Y. Hong et al., "Bone marrowderived cells express matrix metalloproteinases and contribute to regression of liver fibrosis in mice, " Hepatology, vol. 45, no. 1, pp. 213-222, 2007.
22. F. P. Russo, M. R. Alison, B. W. Bigger et al., "The bonemarrow functionally contributes to liver fibrosis, " Gastroenterology, vol. 130, no. 6, pp. 1807-1821, 2006.
23. A. I. Caplan and J. E. Dennis, "Mesenchymal stem cells as trophic mediators, " Journal of Cellular Biochemistry, vol. 98, no. 5, pp. 1076-1084, 2006.
24. S. E. Haynesworth, M. A. Baber, and A. I. Caplan, "Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha, " Journal of Cellular Physiology, vol. 166, pp. 585-592, 1996.
25. D. Nierhoff, A. Ogawa, M. Oertel, Y.-Q. Chen, and D. A. Shafritz, "Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity, " Hepatology, vol. 42, no. 1, pp. 130-139, 2005.
26. H. Strick-Marchand, S. Morosan, P. Charneau, D. Kremsdorf, and M. C. Weiss, "Bipotential mouse embryonic liver stem cell lines contribute to liver regeneration and differentiate as bile ducts and hepatocytes, " Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 101, no. 22, pp. 8360-8365, 2004.
27. X. Ma, Y. Duan, C. J. Jung, J. Wu, C. A. VandeVoort, and M. A. Zern, "Thedifferentiation of hepatocyte-like cells frommonkey embryonic stem cells, " Cloning and Stem Cells, vol. 10, no. 4, pp. 485-493, 2008.
28. J. Min, C.-Z. Shang, Y.-J. Chen et al., "Selective enrichment of hepatocytes from mouse embryonic stem cells with a culture system containing cholestatic serum, " Acta Pharmacologica Sinica, vol. 28, no. 12, pp. 1931-1937, 2007.
29. E. Lagasse, H. Connors, M. Al-Dhalimy et al., "Purified hematopoietic stem cells can differentiate into hepatocytes in vivo, " Nature Medicine, vol. 6, no. 11, pp. 1229-1234, 2000.